NASDAQ · Drug Manufacturers - Specialty & Generic

RMTI (RMTI) Stock

$7.00 +5.58% NASDAQ: RMTI Healthcare

Valuation

MetricValue
Price$7.00
Market Cap$27.63M
P/E Ratio-5.33
P/B Ratio0.85
P/S Ratio0.46
EPS (TTM)$-0.15
52-Week High$7.04
52-Week Low$0.55
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-13.51%
ROA-8.77%
ROCE-13.51%
Gross Margin-7.25%
Operating Margin-7.25%
Net Margin-9.25%
Debt/Equity0.40
Current Ratio3.80

Annual Financials (USD)

Metric20212022202320242025
Revenue$62.0M$73.0M$84.0M$101.0M$69.0M
Operating Profit$-30.0M$-17.0M$-7.0M$1.0M$-5.0M
Net Profit$-33.0M$-19.0M$-8.0M$0$-5.0M
EPS$-3.83$-1.89$-0.36$-0.03$-0.15
Op Margin-49.0%-23.1%-8.0%0.6%-6.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$49.0M$47.0M$52.0M$59.0M$57.0M
Total Liabilities$46.0M$33.0M$31.0M$27.0M$20.0M
Cash$13.0M$10.0M$9.0M$16.0M$25.0B
Borrowings$29.0M$16.0M$13.0M$14.0M$12.0M

Latest News

Rockwell Medical Advances Quality and Regulatory Leadership Business Wire · Jul 22, 2026 Rockwell Medical Regains Compliance With Nasdaq Minimum Bid Price Requirement MT Newswires · Jul 20, 2026 Rockwell Medical Regains Compliance with Nasdaq Listing Requirements Business Wire · Jul 20, 2026 Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026 Business Wire · Jul 16, 2026 Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates Zacks · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-17.0M$-9.0M$4.0M$-1.0M
Investing Cash Flow$0$-3.0M$-3.0M$-6.0M$-9.0M
Financing Cash Flow$0$0$0$-2.0M$-2.0M
Net Cash Flow$-35.0M$-3.0M$-1.0M$7.0M$-5.0M
Free Cash Flow$-34.0M$-17.0M$-10.0M$3.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield5.62%
Quick Ratio3.43
Interest Coverage-5.00
Return 1Y-48.26%
Return 3Y-82.32%
Return 5Y-93.07%

Ownership

Insiders Held15.12%
Institutions Held10.08%
Institutions Float Held11.87%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC118,2362026-03-31
Renaissance Technologies, LLC63,9122026-03-31
Geode Capital Management, LLC42,9182026-03-31
Blackrock Inc.23,6682026-03-31
Vanguard Fiduciary Trust Co23,1262026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APUS $5.15 +4.67% -7.51 $7.77M 0.00%
ATHEAlterity Therapeutics Limited $4.70 -5.62% -6.89 $42.60M 0.00%
CPIX $6.87 -2.28% -28.95 $102.93M 0.00%
EVAXEvaxion Biotech A/S $3.05 +0.66% -1.99 $19.27M 0.00%
LIMNLiminatus Pharma, Inc. Class A Common Stock $0.10 -8.39% -0.27 $2.73M 0.00%

About RMTI

RMTI is led by CEO Mark Strobeck, employs 244 people, headquartered in US, publicly traded since 1998.

RMTI stock trades at $7.00 with a market capitalization of $27.63M. The stock is valued at a price-to-earnings (P/E) ratio of -5.33, price-to-book of 0.85, price-to-sales of 0.46. Over the past 52 weeks the stock has ranged between $0.55 and $7.04, and currently trades at its 52-week high.

On profitability, RMTI generates a return on equity (ROE) of -13.51%, return on capital employed of -13.51%, an operating margin of -7.25%, a net profit margin of -9.25%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides